can glp 1 cause liver damage Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective Glucagon-like peptide (GLP)-1 and GLP-2

HGF acts at the c-Met receptor to stimulate mitogenesis, motogenesis and morphogenesis in a number of cellular targets including epithelial, endothelial and neurons [51,70,71]

Muscle preservation during weight loss depends on adequate protein and resistance training

Remember, there is no substitute for a healthy diet and an active lifestyle

The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (74)